It has also been found that CMG2 activates the metastasis-related urokinase-type plasminogen activator (u-PA) system in soft tissue sarcoma, further promoting cell migration, invasion and epithelial mesenchymal transition (EMT) [14]. This evidence concerns the gene PLAU and soft tissue sarcoma.